Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer

被引：2

作者：

Chen, Jibing ^{[1
,2
,3
]}

Wu, Fasheng ^{[3
]}

Hou, Encun ^{[3
]}

Zeng, Jianying ^{[1
,2
]}

Li, Fujun ^{[3
]}

Gao, Hongjun ^{[3
,4
]}

机构：

[1] Jinan Univ, Guangzhou, Guangdong, Peoples R China

[2] Jinan Univ, Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China

[3] Guangxi Univ Chinese Med, Ruikang Hosp, Nanning, Guangxi, Peoples R China

[4] Guangxi Univ Tradit Chinese Med, Ruikang Hosp, 10 Huadong Rd, Nanning 530011, Guangxi, Peoples R China

来源：

TECHNOLOGY IN CANCER RESEARCH & TREATMENT | 2023年 / 22卷

关键词：

exosomes; microRNA; mRNA; signal pathway; non-small cell lung cancer (NSCLC); ACQUIRED-RESISTANCE; EGFR-TKI; PROLIFERATION; DELIVERY; BIOMARKER; INVASION; MIRNA;

D O I：

10.1177/15330338231210731

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With the progress of molecular diagnosis research on non-small cell lung cancer (NSCLC) cells, four identified categories of microRNAs have been found to be related to disease diagnosis, diagnosis of treatment resistance, prediction of prognosis, and drugs for treatment. To date, nine target mRNA/signal pathways have been confirmed for microRNA drug therapy both in vitro and in vivo. When microRNA drugs enter blood vessels, they target the tumor site and play a similar role to that of targeted drugs. However, whether they will produce serious off-target effects remains unknown, and further clinical research is needed. This review provides the first summary of microRNA therapy for NSCLC.

引用

页数：7

共 50 条

[1] Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
Chen, Jibing
Wu, Fasheng
Hou, Encun
Zeng, Jianying
Li, Fujun
Gao, Hongjun
[J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
[2] Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer
Zheng, Bokun
Peng, Mingcheng
Gong, Jun
Li, Changsheng
Cheng, Hongbing
Li, Yirong
Tang, Yueting
[J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 248 (16) : 1403 - 1413
[3] Targeted therapy for non-small-cell lung cancer
Belani, CP
[J]. LUNG CANCER, 2004, 45 : S7 - S7
[4] Targeted therapy for non-small-cell lung cancer
Rasul, K. T.
Al-Khater, A. M.
[J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2010, 40 (03): : 221 - 221
[5] Adjuvant therapy for non-small-cell lung cancer
Kalemkerian, Gregory P.
[J]. LANCET, 2010, 375 (9722): : 1230 - 1231
[6] Systemic therapy in non-small-cell lung cancer
Jazieh, Abdul-Rahman
Saadeen, Ahmed
[J]. ANNALS OF THORACIC MEDICINE, 2008, 3 (06) : S97 - S99
[7] Hycamtin in the therapy of non-small-cell lung cancer
Gatzemeier, U
[J]. ONKOLOGIE, 1998, 21 : 18 - 21
[8] Individualized therapy of non-small-cell lung cancer
Rosell, R
[J]. LUNG CANCER, 2004, 45 : S19 - S19
[9] Maintenance therapy in non-small-cell lung cancer
Schmid-Bindert, Gerald
[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (02) : 105 - 110
[10] Radiation Therapy in Non-Small-Cell Lung Cancer
Dohopolski, Michael
Gottumukkala, Sujana
Gomez, Daniel
Iyengar, Puneeth
[J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (10):

← 1 2 3 4 5 →